financetom
Business
financetom
/
Business
/
Fitch places some Adani bonds on negative watch after US bribery charges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fitch places some Adani bonds on negative watch after US bribery charges
Nov 25, 2024 6:21 PM

(Reuters) -Ratings agency Fitch has put some of Adani Group's bonds on watch for a possible downgrade after some of the firm's key executives were indicted by U.S. authorities on bribery charges.

Adani Energy Solutions Ltd, Adani Electricity Mumbai and some of Adani Ports and Special Economic Zone rupee and dollar bonds are now on "watch negative", Fitch said.

Ratings on four Adani subsidiary senior unsecured dollar bonds were downgraded from stable to negative, the agency said.

Fitch said it would monitor the U.S. investigation for any impact on Adani's financial position, "particularly any material deterioration in near- to medium-term funding access, including their ability to roll over existing credit lines or access new facilities, as well as potentially higher credit spreads".

French oil major TotalEnergies said on Monday it would halt financial contributions to its Adani Group investments following last week's indictment.

U.S. prosecutors have charged billionaire Gautam Adani, founder of the Adani Group, and seven others for their alleged roles in a $265 million scheme to bribe Indian officials to secure power-supply deals.

The Adani Group has said the accusations as well as those levelled by the U.S. Securities and Exchange Commission in a parallel civil case were "baseless and denied" and that it would "seek all possible legal recourse".

Adani dollar bonds steadied on Tuesday and prices rose slightly after three days of heavy falls.

Prices on some of the more liquid Adani Ports and Special Economic Zone debts maturing between 2027 and 2041 were up between half a cent and 1.5 cents on the dollar. They have fallen about 8-12 cents since news of the indictment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca Plans Direct Listing of Shares on NYSE
AstraZeneca Plans Direct Listing of Shares on NYSE
Sep 29, 2025
04:48 AM EDT, 09/29/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday it plans a direct listing of its shares on the New York Stock Exchange, replacing the existing US listing of its American depositary receipts on Nasdaq. The company's board recommended to its shareholders a harmonized listing structure for its shares across the London Stock Exchange, Nasdaq Stockholm...
Indonesian anti-monopoly agency fines TikTok for late reporting of Tokopedia deal
Indonesian anti-monopoly agency fines TikTok for late reporting of Tokopedia deal
Sep 29, 2025
JAKARTA (Reuters) -TikTok has been fined 15 billion rupiah ($900,000) for the late reporting of its acquisition of e-commerce platform Tokopedia, Indonesia's anti-monopoly agency said on Monday. TikTok, which is owned by China's ByteDance,  completed a deal in January 2024 to buy 75.01% of Tokopedia for $840 million from PT GoTo Gojek Tokopedia. ($1 = 16,665 rupiah) ...
Biogen, Eisai Say China Approves Maintenance Dosing Regimen for Alzheimer's Drug
Biogen, Eisai Say China Approves Maintenance Dosing Regimen for Alzheimer's Drug
Sep 29, 2025
04:53 AM EDT, 09/29/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Sunday their Alzheimer's therapy Leqembi has been approved for once every four weeks intravenous maintenance dosing by the National Medical Products Administration in China. Leqembi was earlier approved for the treatment of Alzheimer's disease in patients with mild cognitive impairment or mild dementia stage of disease in China,...
GSK Names Luke Miels CEO Designate
GSK Names Luke Miels CEO Designate
Sep 29, 2025
04:49 AM EDT, 09/29/2025 (MT Newswires) -- GSK (GSK) said Monday it has appointed Luke Miels chief executive officer designate. Miels, who most recently served as the company's chief commercial officer, will assume the role and join the board on Jan. 1, succeeding Emma Walmsley. Walmsley is stepping down from GSK and is planning to pursue new ventures. Shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved